References - Mach F, et al. Eur Heart J. 2020;41(1):111–188
- Kronenberg F, et al. Eur Heart J. 2022;43(39):3925–3946
- Grundy SM, et al. Circulation. 2019;139(25):e1082–e1143
- Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientifi c statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;S1933-2874(24)00033-3. https://doi.org/10.1016/j.jacl.2024.03.001
- Boerwinkle E, et al. J Clin Invest. 1992;90(1):52–60
- Kraft HG, et al. Hum Genet. 1992;90(3):220–230
- Kronenberg F. Cardiovasc Drugs Ther. 2016;30(1):87–100
- Coassin S & Kronenberg F. Atherosclerosis. 2022;349:17–35
- Erqou S, et al. JAMA. 2009;302(4);412–423;Kamstrup PR, et al. JAMA. 2009;301(22):2331‒2339
- Clarke R, et al. N Engl J Med. 2009;361(26):2518‒2528; Langsted A, et al. J Am Coll Cardiol. 2019;74(1):54–66
- Larsson SC, et al. Circulation. 2020;141(22):1826–1828
- Arsenault BJ & Kamstrup PR. Atherosclerosis. 2022;49:7–16
- Welsh P, et al. Eur J Prev Cardiol. 2022;28(18):1991–2000
- Kronenberg F. Atherosclerosis. 2022;349:123–135
|